透景生命
(300642)
| 流通市值：30.47亿 | | | 总市值：35.97亿 |
| 流通股本：1.38亿 | | | 总股本：1.63亿 |
| 报告期 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 一、营业总收入 | 257,613,224.35 | 159,060,272.81 | 74,893,130.45 | 436,781,430.69 |
| 营业收入 | 257,613,224.35 | 159,060,272.81 | 74,893,130.45 | 436,781,430.69 |
| 利息收入 | - | 0 | 0 | - |
| 已赚保费 | - | 0 | 0 | - |
| 手续费及佣金收入 | - | 0 | 0 | - |
| 二、营业总成本 | 237,122,494.65 | 147,077,994.72 | 73,541,389.21 | 373,365,191.17 |
| 营业成本 | 86,054,550.82 | 54,627,316.59 | 27,214,482.93 | 147,867,692.12 |
| 税金及附加 | 3,265,167.76 | 1,771,764.54 | 794,556.43 | 4,875,234.6 |
| 销售费用 | 80,178,823.62 | 51,277,515.12 | 25,885,452.21 | 130,716,399.68 |
| 管理费用 | 30,967,036.28 | 18,818,288.3 | 9,927,386.91 | 31,516,158.24 |
| 研发费用 | 39,990,947.86 | 23,075,661.88 | 11,057,969.71 | 65,722,373.17 |
| 财务费用 | -3,334,031.69 | -2,492,551.71 | -1,338,458.98 | -7,332,666.64 |
| 其中:利息费用 | 429,333.15 | 150,332.05 | 149,372.76 | 500,088.71 |
| 其中:利息收入 | 4,573,783.94 | 3,253,352.25 | 1,537,586.52 | 7,899,422.57 |
| 三、其他经营收益 | | | | |
| 加:公允价值变动收益 | 726,383.1 | 1,373,190.52 | 461,964.39 | -173,036.11 |
| 加:投资收益 | -6,049,434.19 | -2,729,050.26 | 1,680,393.05 | -9,376,386.55 |
| 汇兑收益 | - | 0 | 0 | - |
| 资产处置收益 | -3,950.86 | -3,725.5 | -10,174.45 | 4,082,665.37 |
| 资产减值损失(新) | -3,424,364.04 | -3,424,364.04 | 0 | -11,165,136.41 |
| 信用减值损失(新) | -12,578,990.17 | -10,017,592.55 | -5,589,479.03 | -16,092,645.15 |
| 其他收益 | 4,022,602.4 | 3,520,337.02 | 1,021,615.65 | 7,935,221.76 |
| 四、营业利润 | 3,182,975.94 | 701,073.28 | -1,083,939.15 | 38,626,922.43 |
| 加:营业外收入 | 228,363.52 | 67,715.27 | 5,715.27 | 86,359.19 |
| 减:营业外支出 | 293,394.78 | 52,690.31 | 511.65 | 2,949,434.48 |
| 五、利润总额 | 3,117,944.68 | 716,098.24 | -1,078,735.53 | 35,763,847.14 |
| 减:所得税费用 | 278,162.4 | 383,051.05 | -154,497.33 | 7,387,100.66 |
| 六、净利润 | 2,839,782.28 | 333,047.19 | -924,238.2 | 28,376,746.48 |
| (一)按经营持续性分类 | | | | |
| 持续经营净利润 | 2,839,782.28 | 333,047.19 | -924,238.2 | 28,376,746.48 |
| (二)按所有权归属分类 | | | | |
| 归属于母公司股东的净利润 | 5,774,947.62 | 2,759,288.75 | 471,691.09 | 34,534,995.78 |
| 少数股东损益 | -2,935,165.34 | -2,426,241.56 | -1,395,929.29 | -6,158,249.3 |
| 扣除非经常损益后的净利润 | 1,373,249.07 | -1,864,129.76 | -2,213,460.83 | 25,964,799.61 |
| 七、每股收益 | | | | |
| (一)基本每股收益 | 0.04 | 0.02 | 0 | 0.21 |
| (二)稀释每股收益 | 0.04 | 0.02 | 0 | 0.21 |
| 八、其他综合收益 | 220,689.42 | 327,575.09 | 250,585.36 | -3,702,354.65 |
| 归属于母公司股东的其他综合收益 | 220,689.42 | 327,575.09 | 250,585.36 | -3,702,354.65 |
| 九、综合收益总额 | 3,060,471.7 | 660,622.28 | -673,652.84 | 24,674,391.83 |
| 归属于母公司股东的综合收益总额 | 5,995,637.04 | 3,086,863.84 | 722,276.45 | 30,832,641.13 |
| 归属于少数股东的综合收益总额 | -2,935,165.34 | -2,426,241.56 | -1,395,929.29 | -6,158,249.3 |
| 公告日期 | 2025-10-23 | 2025-08-27 | 2025-04-28 | 2025-04-19 |
| 审计意见(境内) | | | | 标准无保留意见 |